Skip to main content
SpringerLink
Log in

Tumour suppressive function of HUWE1 in thyroid cancer

  • Published:
Journal of Biosciences Aims and scope Submit manuscript

Abstract

HUWE1 (the HECT, UBA, and WWE domain-containing protein 1) is an ubiquitin E3 ligase which plays an important role in coordinating diverse cellular processes. It has been found to be dysregulated in various cancer type and its functions in tumorigenesis remain controversial. The potential tumour suppressive role of HUWE1 in thyroid cancer development was investigated by knocking down HUWE1 in three authentic thyroid cancer cell lines, WRO, FTC133 and BCPAP, followed by various functional assays, including cell proliferation, scratch wound healing and invasion assays. Xenograft experiment was performed to examine in vivo tumour suppressive properties of HUWE1. Small-interfering RNA mediated knockdown of HUWE1 promoted cell proliferation, cell migration and invasion in thyroid cancer cells. Overexpression of HUWE1 conferred partial sensitivity to chemo drugs interfering with DNA replication in these cells. Moreover, HUWE1 was found to be down-regulated in human thyroid cancer tissues compared with matched normal thyroid tissues. In addition, overexpression of HUWE1 significantly inhibited tumour growth in vivo using xenograft mouse models. Mechanistic investigation revealed that HUWE1 can regulate p53 protein level through its stabilization. HUWE1 functions as a tumour suppressor in thyroid cancer progression, which may represent a novel therapeutic target for prevention or intervention of thyroid cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  • Adhikary S, Marinoni F, Hock A, Hulleman E, Popov N, Beier R, Bernard S, Quarto M, et al. 2005 The ubiquitin ligase HectH9 regulates transcriptional activation by Myc and is essential for tumor cell proliferation. Cell 123 409–421

    Article  CAS  PubMed  Google Scholar 

  • Atsumi Y, Minakawa Y, Ono M, Dobashi S, Shinohe K, Shinohara A, Takeda S, Takagi M, et al. 2015 ATM and SIRT6/SNF2H mediate transient H2AX stabilization when DSBs form by blocking HUWE1 to allow efficient gammaH2AX Foci formation. Cell Rep. 13 2728–2740

    Article  CAS  PubMed  Google Scholar 

  • Bernassola F, Karin M, Ciechanover A and Melino G 2008 The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14 10–21

    Article  CAS  PubMed  Google Scholar 

  • Catalano MG, Poli R, Pugliese M, Fortunati N and Boccuzzi G 2010 Emerging molecular therapies of advanced thyroid cancer. Mol. Asp. Med. 31 215–226

    Article  CAS  Google Scholar 

  • Chen D, Kon N, Li M, Zhang W, Qin J and Gu W 2005 ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor. Cell 121 1071–1083

    Article  CAS  PubMed  Google Scholar 

  • Chen C, Sun X, Guo P, Dong XY, Sethi P, Zhou W, Zhou Z, Petros J, et al. 2007a Ubiquitin E3 ligase WWP1 as an oncogenic factor in human prostate cancer. Oncogene 26 2386–2394

    Article  CAS  PubMed  Google Scholar 

  • Chen C, Zhou Z, Ross JS, Zhou W and Dong JT 2007b The amplified WWP1 gene is a potential molecular target in breast cancer. Int. J. Cancer 121 80–87

    Article  CAS  PubMed  Google Scholar 

  • Confalonieri S, Quarto M, Goisis G, Nuciforo P, Donzelli M, Jodice G, Pelosi G, Viale G, et al. 2009 Alterations of ubiquitin ligases in human cancer and their association with the natural history of the tumor. Oncogene 28 2959–2968

    Article  CAS  PubMed  Google Scholar 

  • Di J, Huang H, Qu D, Tang J, Cao W, Lu Z, Cheng Q, Yang J, et al. 2015 Rap2B promotes proliferation, migration, and invasion of human breast cancer through calcium-related ERK1/2 signaling pathway. Sci. Rep. 5 12363

    Article  PubMed  PubMed Central  Google Scholar 

  • Hall JR, Kow E, Nevis KR, Lu CK, Luce KS, Zhong Q and Cook JG 2007 Cdc6 stability is regulated by the Huwe1 ubiquitin ligase after DNA damage. Mol. Biol. Cell 18 3340–3350

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hao Z, Duncan GS, Su YW, Li WY, Silvester J, Hong C, You H, Brenner D, et al. 2012 The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J. Exp. Med. 209 173–186

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Inoue S, Hao Z, Elia AJ, Cescon D, Zhou L, Silvester J, Snow B, Harris IS, et al. 2013 Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15. Genes Dev. 27 1101–1114

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Liu Z, Oughtred R and Wing SS 2005 Characterization of E3Histone, a novel testis ubiquitin protein ligase which ubiquitinates histones. Mol. Cell Biol. 25 2819–2831

  • Markkanen E, van Loon B, Ferrari E, Parsons JL, Dianov GL and Hubscher U 2012 Regulation of oxidative DNA damage repair by DNA polymerase lambda and MutYH by cross-talk of phosphorylation and ubiquitination. Proc. Natl. Acad. Sci. USA 109 437–442

  • Paricharttanakul NM, Saharat K, Chokchaichamnankit D, Punyarit P, Srisomsap C and Svasti J 2016 Unveiling a novel biomarker panel for diagnosis and classification of well-differentiated thyroid carcinomas. Oncol. Rep

  • Parsons JL, Tait PS, Finch D, Dianova II, Edelmann MJ, Khoronenkova SV, Kessler BM, Sharma RA, et al. 2009 Ubiquitin ligase ARF-BP1/Mule modulates base excision repair. EMBO J. 28 3207–3215

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Saiselet M, Floor S, Tarabichi M, Dom G, Hebrant A, van Staveren WC and Maenhaut C 2012 Thyroid cancer cell lines: an overview. Front. Endocrinol. 3 133

    Article  CAS  Google Scholar 

  • Siegel RL, Miller KD and Jemal A 2016 Cancer statistics 2016. CA Cancer J. Clin. 66 7–30

    Article  PubMed  Google Scholar 

  • Wang X, Lu G, Li L, Yi J, Yan K, Wang Y, Zhu B, Kuang J, et al. 2014 HUWE1 interacts with BRCA1 and promotes its degradation in the ubiquitin-proteasome pathway. Biochem. Biophys. Res. Commun. 444 290–295

    Article  CAS  PubMed  Google Scholar 

  • Xing M 2010 Prognostic utility of BRAF mutation in papillary thyroid cancer. Mol. Cell. Endocrinol. 321 86–93

    Article  CAS  PubMed  Google Scholar 

  • Yoon SY, Lee Y, Kim JH, Chung AS, Joo JH, Kim CN, Kim NS, Choe IS, et al. 2005 Over-expression of human UREB1 in colorectal cancer: HECT domain of human UREB1 inhibits the activity of tumor suppressor p53 protein. Biochem. Biophys. Res. Commun. 326 7–17

    Article  CAS  PubMed  Google Scholar 

  • Zhang L, Komurov K, Wright WE and Shay JW 2013 Identification of novel driver tumor suppressors through functional interrogation of putative passenger mutations in colorectal cancer. Int. J. Cancer 132 732–737

    Article  CAS  PubMed  Google Scholar 

  • Zhao X, Heng JI, Guardavaccaro D, Jiang R, Pagano M, Guillemot F, Iavarone A and Lasorella A 2008 The HECT-domain ubiquitin ligase Huwe1 controls neural differentiation and proliferation by destabilizing the N-Myc oncoprotein. Nat. Cell Biol. 10 643–653

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhao X, D'Arca D, Lim WK, Brahmachary M, Carro MS, Ludwig T, Cardo CC, Guillemot F, et al. 2009 The N-Myc-DLL3 cascade is suppressed by the ubiquitin ligase Huwe1 to inhibit proliferation and promote neurogenesis in the developing brain. Dev. Cell 17 210–221

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Zhong Q, Gao W, Du F and Wang X 2005 Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 121 1085–1095

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, Hebei Province, China

    Weiyuan Ma, Pengxin Zhao, Leilei Zang, Kaili Zhang, Haiying Liao & Zhigang Hu

Authors
  1. Weiyuan Ma
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pengxin Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leilei Zang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kaili Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Haiying Liao
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Zhigang Hu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Haiying Liao or Zhigang Hu.

Additional information

Corresponding editor: RITA MULHERKAR

[Ma W, Zhao P, Zang L, Zhang, K Liao H and Hu Z 2016 Tumour suppressive function of HUWE1 in thyroid cancer. J. Biosci.]

Supplementary materials pertaining to this article are available on the Journal of Biosciences Website.

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 969 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ma, W., Zhao, P., Zang, L. et al. Tumour suppressive function of HUWE1 in thyroid cancer. J Biosci 41, 395–405 (2016). https://doi.org/10.1007/s12038-016-9623-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12038-016-9623-z

Keywords

Search

Navigation